A University of Tübingen team has discovered how malformations of the blood vessels can occur in mice—yielding information with possible ramifications for retinal disease
Aug 18, 2022
0
6
What if, in people with blinding retinal disorders, one could simply introduce into the retina healthy photoreceptor cells derived in a dish from stem cells, and restore sight?
Jul 29, 2022
0
87
Using a new imaging technique, researchers from the National Eye Institute have determined that retinal lesions from vitelliform macular dystrophy (VMD) vary by gene mutation. Addressing these differences may be key in designing ...
Jul 28, 2022
0
1
Loss of the protein pigment epithelium-derived factor (PEDF), which protects retinal support cells, may drive age-related changes in the retina, according to a new study in mice from the National Eye Institute (NEI). The ...
Jul 18, 2022
0
55
Under the direction of Boyd Professor Nicolas Bazan, MD, Ph.D., scientists at LSU Health New Orleans Neuroscience Center of Excellence have developed a new, experimental human cell line from retinal pigment epithelial cells. ...
Jul 12, 2022
0
71
A specific cell within our retina, the light-sensitive part of our eyes responsible for sending visual information to our brain, appears to be particularly good at housing Ebola and other viruses, new research has found.
Jun 20, 2022
0
16
Retinitis pigmentosa, a degenerative genetic disease of the eye, is characterized by progressive vision loss, usually leading to blindness. In some patients, structural defects in the photoreceptor cells have been observed, ...
Jun 17, 2022
0
62
As we age, so do our eyes; most commonly, this involves changes to our vision and new glasses, but there are more severe forms of age-related eye problems. One of these is age-related macular degeneration, which affects the ...
Jun 14, 2022
0
132
A new, detailed genetic roadmap of glaucoma—the world's leading cause of irreversible blindness—will help researchers develop new drugs to combat the disease, by identifying potential target areas to stall or reverse ...
Jun 8, 2022
0
73
A 28-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy (LHON) found no significant safety concerns; however, treatment failed to improve or slow vision loss, ...
Jun 2, 2022
0
2
